Safety and Tolerability of Mebendazole in Infants Under 1 Year of Age-Reference-Cited by-同舟云学术

Safety and Tolerability of Mebendazole in Infants Under 1 Year of Age

Published:2021-09-01 Issue: Volume: Page:
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Kahan Yaara¹²,Lugassy-Akian Eve²³,Ovadia Adi²³,Dalal Ilan²³,Somekh Eli²⁴,Tasher Diana¹²

Affiliation:

1. Pediatric Infectious Diseases Unit, Edith Wolfson Medical Center, Holon, Israel

2. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

3. Department of Pediatrics, Edith Wolfson Medical Center, Holon, Israel

4. Department of Pediatrics, Mayanei HaYeshua Medical Center, Bnei-Brak, Israel

Abstract

Abstract This paper presents the largest cohort to date of infants under 1 year of age treated with mebendazole. We evaluated the occurrence of mebendazole-associated clinical and laboratory toxicity as safety data in this age group are currently lacking.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology and Child Health

Link

http://academic.oup.com/jpids/advance-article-pdf/doi/10.1093/jpids/piab077/40210576/piab077.pdf

Reference12 articles.

1. Efficacy and safety of a single dose versus a multiple dose regimen of mebendazole against hookworm infections in children: a randomised, double-blind trial;Palmeirim;EClinicalMedicine,2018

2. Age- and gender-related expression of rat liver cytochrome P450.;Ryan,1993

3. Physiologic changes during growth and development;O’Flaherty;Environ Health Perspect,1994

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms;Cell Death Discovery;2023-05-13

2. Antihelminthic drugs;Side Effects of Drugs Annual;2022